| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.8M | +56.6% |
| R&D Expense | $48.7M | -43.7% |
| SG&A Expense | $24.6M | -41.0% |
| Operating Income | -$92.9M | +23.8% |
| Income Tax | $0 | — |
| Net Income | -$86.1M | +23.6% |
| EPS (Basic) | -$1.43 | +26.7% |
| EPS (Diluted) | -$1.43 | +26.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $84.6M | +31.5% |
| Short-term Investments | $27.9M | -74.4% |
| Current Assets | $115.2M | -35.5% |
| Total Assets | $124.4M | -41.7% |
| Current Liabilities | $15.3M | -38.1% |
| Total Liabilities | $36.8M | -32.1% |
| Stockholders' Equity | $87.6M | -44.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$65.4M | +16.7% |
| Capital Expenditures | $4K | -99.4% |
| Investing Cash Flow | $85.4M | +28.7% |
| Financing Cash Flow | $245K | -56.8% |
| Free Cash Flow | -$65.4M | +17.4% |